Created at Source Raw Value Validated value
Dec. 10, 2021, 2 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "1371 / 5000Resultados de tradu\u00e7\u00e3oExperimental Group: Treatment group with allogeneic mesenchymal stem cells (MSCs): The Experimental Group will consist of 24 participants who will receive treatment with mesenchymal stem cells obtained from dental pulps of primary teeth from 24 donors according to the following protocol : 4 sessions for infusions containing 0.5 x 10E6 MSCs / kg body weight suspended in 100 mL of saline; intravenously on days 1; day 3; day 5 and day 7 of the experimental stage; in patients in moderate stage of disease according to the understanding proposed by the Ministry of Health.Control Group: Placebo. The Placebo Group will consist of 24 participants who will receive treatment with Placebo Solution according to the following protocol:4 sessions for infusions containing the placebo solution (100 mL saline) intravenously on days 1; day 3; day 5 and day 7.All patients will be randomly and blindly distributed between the experimental and placebo groups; following all assumptions to guarantee the Double Blind Study.All patients in the study will receive; in addition to the treatments proposed by this study; according to the group; the conventional treatment protocol at the time; indicated by the hospitals participating in the study; in order to guarantee the patient access to conventional therapy in a complementary way to Study.;DeS: E02.095.147 Terapia Baseada em Transplante de C\u00e9lulas e Tecidos", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 787, "treatment_name": "Mesenchymal stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]